News Mentions for the week of November 6, 2023
Our faculty are often called upon to provide insight on current events and topics in the news.
Explore some of the articles that they have contributed to or been quoted in recently below.
Good News: Your Brain Can Recover From Heavy Drinking
In good news for drinkers, researchers in the US have discovered that the brains of people who suffer from alcohol use disorder and abstained from drinking for roughly 7.3 months displayed significant structural improvements, suggesting remarkable powers of recovery are possible. The “results support the adaptive and beneficial effects of sustained sobriety on brain structural recovery,” the study says. Timothy Durazzo, professor of psychiatry and behavioral sciences, provides comment.
- Manhattan Institute
New Drugs, Old Misery: The Challenge of Fentanyl, Meth, and Other Synthetic Drugs
If, in 2015, someone had told you that the number of overdose deaths caused solely by the two most historically lethal drugs—heroin and cocaine—would drop by more than half by 2021, you would likely have assumed that the overdose crisis in the U.S. was finally coming to an end. Instead, drug overdose deaths soared to more than 100,000 per year due to the rise of synthetic drugs, a truly disruptive innovation with which U.S. drug policy is only beginning to grapple. Keith Humphreys, the Esther Ting Memorial professor of psychiatry and behavioral sciences, coauthors this issue brief with Jonathan Caulkins.
- NY Times
How Do You Deal With Conflicts?
Do you try to face them directly? Or do you tend to avoid confrontation? Karen Osilla, associate professor in psychiatry and behavioral sciences, provides comment.
- Stanford News
How mice choose to eat or to drink
A new Stanford study from researchers in the departments of Biology, Psychiatry and Behavioral Sciences, and Bioengineering uses behavioral analysis, neural engineering, electrophysiology, and math to explore how mice decide whether to eat or drink when they are both hungry and thirsty.
- Chan Zuckerberg Initiative
CZI Neurodegeneration Challenge Network Projects Announced
The Chan Zuckerberg Initiative recently announced the newly funded round of Neurodegeneration Challenge Network (NDCN) Projects. NDCN brings together experimental scientists from diverse research fields, along with computational biologists and physicians, to accelerate fundamental neuroscience and neurodegenerative disease research that leads to an in-depth understanding of healthy brain function and the development of new strategies for treatment and prevention of neurodegenerative disorders. Congratulations to Erin Gibson, assistant professor of psychiatry and behavioral sciences, recipient of the Ben Barres Early Career Acceleration Award!
- National Academies of Sciences, Engineering, and Medicine
National Academies Announce 2023 Recipients of Eric and Wendy Schmidt Awards for Excellence in Science Communications
The National Academies of Sciences, Engineering, and Medicine recently announced this year’s recipients of the Eric and Wendy Schmidt Awards for Excellence in Science Communications, given by the National Academies in partnership with Schmidt Futures. These prestigious awards recognize science journalists, research scientists, and science communicators who have developed creative, original work to communicate issues and advances in science, engineering, and medicine to the general public. Congratulations to Britt Wray, instructor of psychiatry and behavioral sciences, top prize recipient in the Research Scientist: Early Career category!
- Good Morning America
The effect of Ozempic use on mental health
Some psychiatrists are incorporating prescriptions for the diabetes and weight loss drug into their patients’ care. Shebani Sethi, clinical assistant professor of psychiatry and behavioral sciences, is interviewed in this segment.
Ketamine marketed online using false, misleading claims, study indicates
Hundreds of clinics may be using false and misleading statements in online advertising to sell off-label and unapproved ketamine -- an injectable, short-acting anesthetic -- to treat mental health conditions and pain. Smita Das, clinical associate professor of psychiatry and behavioral sciences, provides comment.
- Palo Alto Online
End of daylight saving time this weekend correlated with car crashes, heart attacks
While large swaths of North America still abide by the twice-per-year time change, a recent effort to eliminate the bi-annual changes has sparked conversation about the benefits and disadvantages of this disruption to our routines. Rafael Pelayo, clinical professor of psychiatry and behavioral sciences, provides comment.
How to Know if Your Child Has Seasonal Affective Disorder
Parents magazine turned to pediatric experts to learn more about how the symptoms and treatment of seasonal affective disorder in kids. Victoria Cosgrove, assistant professor of psychiatry and behavioral sciences, is quoted.
- Washington Post
The hunt quickens for vaccines and antibody therapies against opioids
The concept has long tantalized scientists: harnessing antibodies to block the dangerous effects of heroin, cocaine and nicotine. Keith Humphreys, the Esther Ting Memorial professor of psychiatry and behavioral sciences, provides comment.
- Vigour Times
The Impact of Daylight-Saving Time on Seasonal Depression: A Closer Look at the Effects of its End
As daylight-saving time comes to an end on Sunday, evenings will feel even longer and darker. This shift is known to exacerbate feelings of seasonal depression, also known as seasonal affective disorder (SAD), which is often linked with light levels. Kristin Raj, clinical associate professor of psychiatry and behavioral sciences, provides comment.
- NY Times
Some Psychiatrists Have Started Prescribing Ozempic
Doctors say the diabetes medication, and drugs like it, could counteract the weight patients gain on antipsychotics and antidepressants. Shebani Sethi, clinical assistant professor of psychiatry and behavioral sciences, is quoted.